Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy
Authors
Keywords
Duchenne muscular dystrophy, myostatin inhibitor, domagrozumab, 4-stair climb
Journal
NEUROMUSCULAR DISORDERS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-05-19
DOI
10.1016/j.nmd.2020.05.002

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.